Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium

• Published in: Toxicology (Amsterdam) 2007-07, Vol.237 (1), p.89-103
• Main Authors: Brzóska, Malgorzata M, Rogalska, Joanna, Galażyn-Sidorczuk, Malgorzata, Jurczuk, Maria, Roszczenko, Alicja, Kulikowska-Karpińska, Elżbieta, Moniuszko-Jakoniuk, Janina
• Format: Article
• Language: English
• Subjects: Absorptiometry, Photon; Animals; Biological and medical sciences; Body Weight - drug effects; Bone and Bones - drug effects; Bone and Bones - metabolism; Bone Density - drug effects; Bone mineral status; Bone Resorption - chemically induced; Bone Resorption - metabolism; Bone Resorption - prevention & control; Bone turnover; Cadmium; Cadmium Chloride - pharmacokinetics; Cadmium Chloride - toxicity; Calcium - blood; Chemical and industrial products toxicology. Toxic occupational diseases; Chlorides - administration & dosage; Chlorides - pharmacokinetics; Chlorides - pharmacology; Chlorides - therapeutic use; Collagen Type I - blood; Drug Interactions; Emergency; Femur - drug effects; Femur - metabolism; Male; Male rats; Medical sciences; Metals and various inorganic compounds; Osteocalcin - blood; Peptides - blood; Rats; Rats, Wistar; Toxicology; Zinc Compounds - administration & dosage; Zinc Compounds - pharmacokinetics; Zinc Compounds - pharmacology; Zinc Compounds - therapeutic use; Zinc supplementation
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2007.05.001

Abstract The aim of the present study is to investigate, based on the rat model of moderate and relatively high human exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced disorders in bone metabolism. For this purpose, male Wistar rats received Cd (5 and 50 mg/l) or/and Zn (30 and 60 mg/l) in drinking water for 6 and 12 months. Bone densitometry and biochemical markers of bone turnover were used to assess the effects of Cd or/and Zn. Bone mineral content (BMC) and density (BMD) were measured in the femur. Serum osteocalcin (OC) and alkaline phosphatase in trabecular (bT-ALP) and cortical (bC-ALP) bone were determined as bone formation markers, and carboxy-terminal cross-linking telopeptides of type I collagen (CTX) in serum were measured as bone resorption marker. Serum concentration of calcium (Ca) and its renal handling, as well as Zn and Cd concentrations in the serum/blood, urine and femur were evaluated as well. The exposure to 5 and 50 mg Cd/l (0.340 ± 0.026 and 2.498 ± 0.093 mg Cd/kg body wt/24 h, respectively), in a dose and duration dependent manner, affected bone turnover (inhibited bone formation and stimulated its resorption) and disturbed bone mineralization (decreased BMC, BMD and Zn concentration). Zn supply at the concentration of 30 and 60 mg/l (1.904 ± 0.123 and 3.699 ± 0.213 mg/kg body wt/24 h, respectively) during Cd exposure influenced the Cd-induced disorders in bone metabolism. Zn administration to the Cd-exposed rats enhanced the bone ALP activity and prevented Cd-induced bone resorption, but had no statistically significant effect on BMC and BMD; however, mean values of the densitometric parameters in the rats receiving both Cd and Zn were higher than in those treated with Cd alone. Moreover, Zn supplementation at both levels of Cd exposure was found to prevent Cd accumulation in the femur and the Cd-induced decrease in bone Zn concentration. The results of the present study allow the conclusion that Zn supplementation during Cd exposure may partly protect from disorders in bone metabolism. The influence of Zn may be accompanied by its ability to prevent Cd-induced Zn deficiency and to decrease Cd accumulation in bone tissue. The findings seem to indicate that enhanced dietary intake of Zn in subjects chronically exposed to moderate and relatively high Cd levels may have a protective influence on the skeleton.